ASHLEY BLACKWOOD: Open Payments
NPI 1295276285 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 25 payments from 7 companies in 2025. Trend: 2023 $748 · 2024 $972 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $137 |
| PFIZER INC. | 6 | $97 |
| Lilly USA, LLC | 6 | $94 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| Novo Nordisk Inc | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Antares Pharma, Inc. | 1 | $15 |
Products named: UBRELVY, MOUNJARO, PREVNAR 20, TRELEGY ELLIPTA, VRAYLAR, AIRSUPRA, NURTEC ODT, Ozempic.
Industry payments across AR — which companies pay providers there.
